Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-086398

Chief Financial Officer sold 1,005 shares at $1.26 ($1,266)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Knudson Susan A. Chief Financial Officer 2015-12-17 Sale −1,005 $1.26 $1,266 0 D: show line 1 in the form
Open-market sales · 1,005 sh · avg $1.26 · $1,266
Loading xslF345X03/doc4.xml…